Director, Respiratory Bioequivalence Strategy

Viatris (Mylan Pharma UK Limited) is seeking a Director of Respiratory Bioequivalence Strategy to lead the development and execution of BE strategies for inhaled products. You will work with cross-functional teams to define studies, generate regulatory readable data, and present at regulatory meetings.

The role requires deep experience in bioequivalence, regulatory submissions, and collaboration with statisticians and external authorities; a strong track record in respiratory product development